MI
BMRN icon

Montage Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History

Montage Investments’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$1.1M Sell
11,893
-300
-2% -$28.3K 0.6% 57
2016
Q2 		$949K Buy
12,193
+2,188
+22% +$186K 0.66% 58
2016
Q1 		$825K Buy
10,005
+1,690
+20% +$138K 0.59% 67
2015
Q4 		$871K Buy
+8,315
New +$868K 1.71% 24

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Montage Investments's BMRN Position: Q3 2016 in Review

Montage Investments reduced its BioMarin Pharmaceuticals (BMRN) stake by 2.5% in Q3 2016, selling an estimated $28.3K and leaving 11,893 shares worth $1.1M. The position accounts for 0.6% of the portfolio, ranked #57.

Montage Investments first reported a position in BMRN in Q4 2015 and has held it in 4 quarters since. 422 funds tracked by Wall St. Rank hold BMRN as of Q3 2016.

  • Montage Investments held 11,893 shares of BioMarin Pharmaceuticals worth $1.1M as of Q3 2016.
  • Montage Investments sold 300 BioMarin Pharmaceuticals shares in Q3 2016, an estimated $28.3K.
  • BioMarin Pharmaceuticals made up 0.6% of Montage Investments's portfolio in Q3 2016, its #57 holding.
  • Montage Investments first reported a position in BioMarin Pharmaceuticals in Q4 2015 and has held it in 4 quarters since.
  • 422 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2016.

Based on Montage Investments's 13F filing for Q3 2016, filed 10 Nov 2016.